| 股號 / 名稱 | 總負債 | 淨值 |
| MDT 美敦力 | 1,349,680,405,031.28 | 1,538,097,597,872.88 |
| NVO 諾和諾德 | 1,734,794,129,851.91 | 964,961,363,647.86 |
| SYK 史賽克 | 803,744,750,135.04 | 708,777,426,763.2 |
| ZBH Zimmer Biomet Holdings Inc | 339,261,594,795.24 | 403,279,181,289.24 |
| PHG Koninklijke Philips NV | 585,715,312,504.44 | 391,490,972,163.6 |
| BIO Bio Rad Laboratories Inc | 93,563,678,512.42 | 212,974,655,156.93 |
| RMD 瑞思邁 | 68,996,447,587.59 | 199,825,885,481.78 |
| NVST Envista Holdings Corp | 80,750,677,126.73 | 97,629,190,425.07 |
| ICUI ICU Medical Inc | 62,457,327,746.43 | 67,250,079,441.66 |
| NEOG Neogen Corp | 39,689,797,149.48 | 66,530,490,155.84 |
| QDEL QuidelOrtho Corp | 115,032,489,864.55 | 64,377,981,795.74 |
| EYE National Vision Holdings Inc | 34,765,848,918.96 | 27,148,546,466.75 |
| INMD Inmode Ltd | 2,567,658,456.81 | 20,655,867,037.72 |
| TGTX TG Therapeutics Inc | 13,208,361,354.43 | 19,196,360,906.53 |
| ATRC AtriCure Inc | 5,024,511,165.15 | 15,064,112,635.8 |
| WRBY Warby Parker Inc | 10,663,148,569.92 | 11,685,185,386.59 |
| BLFS BioLife Solutions Inc | 1,212,129,531.53 | 11,182,971,372.25 |
| QTRX Quanterix Corp | 4,097,315,217.35 | 9,943,559,284.1 |
| PAHC Phibro Animal Health Corp | 33,948,067,720.24 | 9,853,365,617.8 |
| MRVI Maravai LifeSciences Holdings Inc | 19,086,661,634.85 | 7,759,342,460.17 |
| ORMP Oramed Pharmaceuticals Inc | 544,102,064.76 | 6,426,480,502.55 |
| VALN Valneva SE | 11,046,931,382.08 | 5,582,864,577.17 |
| VMD Viemed Healthcare Inc | 2,173,499,805.75 | 4,223,832,936.44 |
| UTMD Utah Medical Products Inc | 117,697,518.28 | 3,738,374,142.27 |
| CAPR Capricor Therapeutics Inc | 1,345,821,962.35 | 2,651,347,936.33 |
| MGNX MacroGenics Inc | 6,441,655,041.58 | 2,118,144,351.94 |
| CERS Cerus Corp | 4,859,709,348.66 | 1,943,068,107.99 |
| INFU InfuSystem Holdings Inc | 1,372,347,372.69 | 1,753,639,279.21 |
| ZVIA Zevia PBC | 276,903,723.51 | 1,620,198,176.7 |
| RMTI Rockwell Medical Inc | 647,004,407.5 | 1,170,336,321.98 |
| ICCC ImmuCell Corp | 503,582,251.94 | 942,112,519.65 |
| VERU Veru Inc | 363,653,085.59 | 579,562,117.23 |
| XGN Exagen Inc | 1,412,654,741.97 | 573,407,893.25 |
| MYO Myomo Inc | 614,943,451.77 | 462,367,571.69 |
| SNES Senestech Inc | 103,566,228.82 | 358,751,393.35 |
| UG United-Guardian Inc | 50,515,724.26 | 334,549,268.16 |
| PHGE Biomx Inc | 495,764,835.26 | 331,500,450.36 |
| NEPH Nephros Inc | 102,459,752.01 | 316,325,911.34 |
| CLRB Cellectar Biosciences Inc | 165,916,512.84 | 296,514,602.24 |
| CTSO Cytosorbents Corp | 1,161,168,371.32 | 285,154,879.1 |
| APYX Apyx Medical Inc | 1,628,639,014.03 | 184,876,467.07 |
| IMCC IM Cannabis Corp | 917,148,564.63 | 90,035,912.75 |
| GCTK GlucoTrack Inc | 175,107,857.58 | 86,969,076.76 |
| EOLS Evolus Inc | 7,832,496,383.7 | -909,207,796.33 |
| OMER Omeros Corp | 12,840,947,828.38 | -6,970,108,362.97 |
| BRBR Bellring Brands Inc | 49,665,001,670.16 | -16,145,077,245.67 |
載入數據中...
最新要聞
和醫療產品相關的產業概念股
醫療產品概念股相關指標排名
醫療產品每月營收
醫療產品每股盈餘
醫療產品每股淨值
醫療產品損益表
醫療產品總資產
醫療產品負債和股東權益
醫療產品現金流量表
醫療產品利潤比率
醫療產品營業費用率拆解
醫療產品杜邦分析
醫療產品ROE / ROA
醫療產品經營週轉能力
醫療產品營運週轉天數
醫療產品現金股利發放率
醫療產品財務結構比率
醫療產品流速動比率
醫療產品利息保障倍數
醫療產品現金流量分析
醫療產品營業現金流對淨利比
醫療產品盈餘再投資比率
醫療產品月營收成長率
醫療產品營收成長率
醫療產品毛利成長率
醫療產品營業利益成長率
醫療產品稅後淨利成長率
醫療產品每股盈餘成長率
醫療產品本益比評價
醫療產品股價淨值比評價
醫療產品現金股利殖利率
醫療產品平均現金股息殖利率
醫療產品董監持股比例
醫療產品董監持股質押比例